Financial Advocates Investment Management Editas Medicine, Inc. Transaction History

Financial Advocates Investment Management

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$12.16 - $19.42 $95,845 - $153,068	7,882 New	7,882 $943,000
Q4 2020 Feb 12, 2021	SELL	$27.07 - $84.35 $297,770 - $927,849	-11,000 Closed	0 $0
Q3 2020 Nov 04, 2020	SELL	$28.06 - $37.16 $11,224 - $14,863	-400 Reduced 3.51%	11,000 $309,000
Q2 2020 Aug 14, 2020	SELL	$18.5 - $34.34 $7,215 - $13,392	-390 Reduced 3.31%	11,400 $337,000
Q1 2020 Apr 29, 2020	SELL	$14.88 - $32.78 $9,151 - $20,159	-615 Reduced 4.96%	11,790 $234,000
Q4 2019 Feb 13, 2020	SELL	$19.49 - $32.63 $7,503 - $12,562	-385 Reduced 3.01%	12,405 $367,000
Q3 2019 Nov 13, 2019	SELL	$22.49 - $26.81 $15,653 - $18,659	-696 Reduced 5.16%	12,790 $291,000
Q2 2019 Aug 08, 2019	SELL	$20.48 - $27.76 $286 - $388	-14 Reduced 0.1%	13,486 $334,000
Q1 2019 May 16, 2019	BUY	$19.43 - $26.41 $4,857 - $6,602	250 Added 1.89%	13,500 $330,000
Q4 2018 Feb 14, 2019	BUY	$18.19 - $31.79 $10,386 - $18,152	571 Added 4.5%	13,250 $301,000
Q3 2018 Nov 14, 2018	BUY	$27.65 - $38.39 $13,935 - $19,348	504 Added 4.14%	12,679 $0
Q2 2018 Aug 09, 2018	BUY	$31.4 - $41.01 $382,295 - $499,296	12,175 New	12,175 $450,000
Q1 2018 May 11, 2018	SELL	$29.84 - $44.08 $319,288 - $471,656	-10,700 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$21.89 - $31.34 $234,223 - $335,338	10,700	10,700 $319,000

248

57M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $90M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Financial Advocates Investment Management, based on Form 13F filings with the SEC.

Stay updated on Financial Advocates Investment Management with notifications on news.